Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in ...

Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...

These results demonstrate the capacity of the four transcription factors to mediate reprogramming regardless of developmental origins and epigenetic states of a cell. In contrast to keratinocytes ...

The primary cells in the epithelium are the keratinocytes, and they are known to form patterns at the microscopic and macroscopic levels. While factors affecting this pattern formation have been ...

They isolated keratinocytes, cells from the outermost layer of the skin, from diabetic mice and cultured them in lab dishes. Once the cells had formed a layer in the dish, the researchers introduced a ...

A laser used in cosmetic dermatology for nearly 40 years showed properties similar to those seen with other types of lasers.

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abeona Therapeutics Inc.’s (NASDAQ:ABEO) Zevaskyn ...

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

cell differentiation, and inflammation, in view of these binding capacities to various RAR receptors. Tazarotene down-regulates the abnormal expression of keratinocytes, epidermal growth factor ...